Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  CytoTools AG    T5O   DE000A0KFRJ1

CYTOTOOLS AG (T5O)
Mes dernières consult.
Most popular
Rapport
Real-time Quote. Real-time TRADEGATE AG - 10/20 11:01:05 am
10.0050 EUR   -0.45%
05/09 CYTOTOOLS : withdraws planned convertible bond
04/25 CYTOTOOLS : Capital increase
04/25 CYTOTOOLS : Ad hoc Capital increase
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Xetra
10/16/2017 10/17/2017 10/18/2017 10/19/2017 10/20/2017 Date
9.975(c) 10.12(c) 10.055(c) 10.05(c) 10.115 Last
1 260 650 2 020 300 50 Volume
-2.92% +1.45% -0.64% -0.05% +0.65% Change
More quotes
Company
CytoTools AG is an investment holding company, which engages in the development of therapies to treat cause of diseases.It provides treatment options in dermatology, cardiology and angiology, urology, and oncology.Its pipeline includes DermaPro, CardioClean, LMW 0x, HMW 02Ac, and Utisept.The... 
Sector
Biotechnology & Medical Research
Calendar

- No events available -

More about the company
Latest news on CYTOTOOLS AG
05/09 CYTOTOOLS : withdraws planned convertible bond
04/25 CYTOTOOLS : Capital increase
04/25 CYTOTOOLS : Ad hoc Capital increase
04/21 DGAP-NEWS : CytoTools AG schafft mit Kapitalerhöhung die Voraussetzung zur Umset..
04/21 DGAP-ADHOC : CytoTools AG schafft mit einer Barkapitalerhöhung die Voraussetzung..
04/07 DGAP-NEWS : Produktionsstart in Indien
03/30 DGAP-ADHOC : Ausgabe einer Wandelanleihe mit einem Gesamtnennbetrag von bis zu 0..
03/24 DGAP-NEWS : CytoTools AG: DermaPro(R) erhält Marktzulassung in Indien - ein Meil..
03/24 DGAP-ADHOC : CytoTools AG: DermaPro(R) erhält Marktzulassung in Indien
02/16 DGAP-NEWS : CytoTools AG setzt erneut Patentschutz für DermaPro(R) durch
More news
Sector news : Bio Therapeutic Drugs
10/18DJGILEAD SCIENCES : Cell-Therapy Drug Yescarta Gets FDA Approval -- Update
10/18DJGILEAD SCIENCES : Cell-Therapy Drug Yescarta Gets FDA Approval
10/18DJACTELION : J&J Net Income Falls After Actelion Deal -- WSJ
10/17 Regeneron-Sanofi drug succeeds mid-stage study
10/17DJJOHNSON & JOHNSON : Outlook Buoyed by Drug Unit -- Update
More sector news : Bio Therapeutic Drugs
Latest Tweets
05/09CytoTools : withdraws planned convertible bond  
01/21For all my friends in Austria! I'm headed to Igls in two weeks to race. Derek.. 
2016CytoTools : DermaTools action for damages  
2016#Frankfurt #stocks: CytoTools : #Market Analysts conclude unsteady sales prof.. 
2016BRIEF-Cytotools unit signs contracts for production with German manufacturer ..
1
More tweets
Qtime:48
Chart CYTOTOOLS AG
Duration : Period :
CytoTools AG Technical Analysis Chart | T5O | DE000A0KFRJ1 | 4-Traders
Technical analysis trends CYTOTOOLS AG
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Managers
NameTitle
Mark-Andre Freyberg Chief Executive Officer
Manfred May Chairman-Supervisory Board
Matthias Hoffmann Member-Supervisory Board
Bernhard Seehaus Member-Supervisory Board
Peter Friedl Deputy Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
CYTOTOOLS AG16.93%25
GILEAD SCIENCES11.73%104 487
REGENERON PHARMACEUTICALS19.69%47 079
VERTEX PHARMACEUTICALS110.07%39 018
ACTELION23.81%29 869
GENMAB14.75%12 912